What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Sustained abstinence is currently the only accepted end-point for pharmacotherapy trials for most substance use disorders (SUD), with the exception of alcohol. Despite recent efforts, the identification of a non-abstinence alternative as a clinically meaningful end-point for drug use trials has been...
Сохранить в:
| Главный автор: | |
|---|---|
| Другие авторы: | |
| Формат: | Journal Article |
| Язык: | английский |
| Предметы: | |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
Ваш комментарий будет первым!